Altered sphingolipid metabolism in human endometrial cancer.
about
The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines.Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancerHigh expression of SPHK1 in sacral chordoma and association with patients' poor prognosis.Sphingosine kinase 1 in cancer.Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.Identification of miR-145 targets through an integrated omics analysis.Sources, metabolism, and regulation of circulating sphingosine-1-phosphateOncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner.Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapyInterference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells.H-Ras increases release of sphingosine resulting in down-regulation of TSP-1 in non-transformed cells.Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
P2860
Q30301001-365C8064-2994-4081-B6EC-8FE2984DA327Q31114377-ACF3E80D-04AB-47EF-8FCD-974F3AADCFC6Q33275396-AA2517CA-3797-4342-B3E3-2D2A2EDFB426Q33853998-959F01B7-1469-4D00-A7D9-5A5C2D7ACC02Q35108994-73AD7551-81B0-4564-B3D6-93EF8275041DQ35155627-B7657B5F-B3CB-4F01-9A7F-7516328FFA22Q35776618-FEFFCCB5-3EBB-47D3-8C4E-D0F258492B1BQ36234717-6033A96E-FC21-435C-8B8D-AFA3AF08EFF8Q37269206-832837E8-A1D5-44F2-8038-912346DE13F2Q37808219-B7E5F8F2-8452-4119-910E-7AE3CBF8CC13Q37905015-D403534D-8387-4877-87D9-E1DB7B751916Q38871772-8211B3FF-07F2-4F9C-A005-D56D31244738Q39392240-C39C1423-17BB-4B7E-9D6B-EA515067D0A6Q52624560-162221C0-5C72-4AE3-A6E3-DDCE309E7470Q53185416-7C662FC1-976E-49A4-927C-9633B0EDF1E4
P2860
Altered sphingolipid metabolism in human endometrial cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Altered sphingolipid metabolism in human endometrial cancer.
@en
Altered sphingolipid metabolism in human endometrial cancer.
@nl
type
label
Altered sphingolipid metabolism in human endometrial cancer.
@en
Altered sphingolipid metabolism in human endometrial cancer.
@nl
prefLabel
Altered sphingolipid metabolism in human endometrial cancer.
@en
Altered sphingolipid metabolism in human endometrial cancer.
@nl
P2093
P50
P1476
Altered sphingolipid metabolism in human endometrial cancer
@en
P2093
Małgorzata Knapp
Paweł Knapp
Piotr Zabielski
P356
10.1016/J.PROSTAGLANDINS.2010.03.002
P577
2010-03-10T00:00:00Z